Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 11

1.

Impact of dietary aromatic amino acids on osteoclastic activity.

Refaey ME, Zhong Q, Ding KH, Shi XM, Xu J, Bollag WB, Hill WD, Chutkan N, Robbins R, Nadeau H, Johnson M, Hamrick MW, Isales CM.

Calcif Tissue Int. 2014 Aug;95(2):174-82. doi: 10.1007/s00223-014-9878-z. Epub 2014 Jul 8.

2.

Safety of Anti-Diabetic Therapies on Bone.

Lecka-Czernik B.

Clin Rev Bone Miner Metab. 2013 Mar 1;11(1):49-58. Epub 2012 Feb 7.

3.

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore DR, Qualls C, Villareal DT.

J Bone Miner Res. 2012 May;27(5):1215-21. doi: 10.1002/jbmr.1560.

4.

Cellular and molecular effects of thiazolidinediones on bone cells: a review.

Mabilleau G, Chappard D, Baslé MF.

Int J Biochem Mol Biol. 2011;2(3):240-6. Epub 2011 Jun 20.

5.

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children.

Wasilewska A, Rybi-Szuminska A, Zoch-Zwierz W.

Pediatr Nephrol. 2010 Oct;25(10):2067-75. doi: 10.1007/s00467-010-1583-1. Epub 2010 Jul 4.

6.

Role of muscle-derived growth factors in bone formation.

Hamrick MW, McNeil PL, Patterson SL.

J Musculoskelet Neuronal Interact. 2010 Mar;10(1):64-70.

7.

Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight.

Baldock PA, Lee NJ, Driessler F, Lin S, Allison S, Stehrer B, Lin EJ, Zhang L, Enriquez RF, Wong IP, McDonald MM, During M, Pierroz DD, Slack K, Shi YC, Yulyaningsih E, Aljanova A, Little DG, Ferrari SL, Sainsbury A, Eisman JA, Herzog H.

PLoS One. 2009 Dec 22;4(12):e8415. doi: 10.1371/journal.pone.0008415.

8.

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone.

Syversen U, Stunes AK, Gustafsson BI, Obrant KJ, Nordsletten L, Berge R, Thommesen L, Reseland JE.

BMC Endocr Disord. 2009 Mar 30;9:10. doi: 10.1186/1472-6823-9-10.

9.

Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial.

Villareal DT, Shah K, Banks MR, Sinacore DR, Klein S.

J Clin Endocrinol Metab. 2008 Jun;93(6):2181-7. doi: 10.1210/jc.2007-1473. Epub 2008 Mar 25.

10.

Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone.

Shi X, Hamrick M, Isales CM.

PPAR Res. 2007;2007:92501. doi: 10.1155/2007/92501.

11.

Impact of glucose-dependent insulinotropic peptide on age-induced bone loss.

Ding KH, Shi XM, Zhong Q, Kang B, Xie D, Bollag WB, Bollag RJ, Hill W, Washington W, Mi QS, Insogna K, Chutkan N, Hamrick M, Isales CM.

J Bone Miner Res. 2008 Apr;23(4):536-43.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk